TREM2 and Alzheimer disease: Wang and colleagues (2020) have indicated that treating Aβ accumulation in AD mouse models expressing either the common variant or the R47H variant of TREM2 with TREM2 agonistic mAb, AL002, reduced Aβ plaques, and neuronal loss and improved cognitive function [246].